Search
Search Results
##search.searchResults.foundPlural##
-
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2033PDF: 825HTML: 226 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1532PDF: 942HTML: 222 -
THE CHALLENGE OF AML IN OLDER PATIENTS
2179PDF: 951HTML: 2162 -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
819PDF: 540HTML: 4019 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3699PDF: 1444HTML: 182 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7444PDF: 2422HTML: 1733Table 1.: 208Table 2.: 217Table 3.: 202Table 4.: 200 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3371PDF: 1280HTML: 2215Fi.1 Gritti.Rambaldi: 205 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
1959PDF: 712HTML: 684Table1: patient's characteristics: 155Table 2: profile of each patient: 178 -
IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA? MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA
2546PDF: 1132HTML: 142 -
POST-TRANSPLANT RELAPSE IN ACUTE LEUKEMIA: COMPARATIVE VALUE OF MRD AND CHIMERISM.
714PDF: 419Suppl. Files: 120HTML: 112 -
NASAL NK/T- CELL LYMPHOMA. COMPARATIVE ANALYSIS OF A MEXICAN POPULATION
1767PDF: 993HTML: 1784Tables: 179 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1045PDF: 1156Suppl. Files: 569HTML: 88 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
481PDF: 243HTML: 79 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
3923Suppl. Files: 1118PDF: 1066Html: 177 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1725PDF: 1163HTML: 246 -
ASSOCIATION BETWEEN PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE INFECTION PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE
154PDF: 183Suppl. Files: 31HTML: 20 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2801PDF: 1009HTML: 5520 -
ADVANCED HODGKIN LYMPHOMA: A NEW ERA OF THERAPY
2138PDF: 1323HTML: 3501 -
Azacytidine failure revisited: an appraisal based on real life data from the MDS registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS). Azacytidine failure revisited
1083PDF: 843HTML: 238 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4502PDF: 1924HTML: 17765 -
CANDIDA ASSOCIATED BLOODSTREAM INFECTIONS IN PEDIATRIC HEMATOLOGY PATIENTS: SINGLE CENTER EXPERIENCE
4367PDF: 909HTML: 1325Table1: 181 -
CEREBRAL VENOUS THROMBOSIS IN THE MEDITERRANEAN AREA IN CHILDREN
2515PDF: 947HTML: 2233 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2609PDF: 1611HTML: 2354Table1: 190 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
2883PDF: 1360HTML: 3569Untitled: 192Untitled: 202Untitled: 177 -
IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination
1429PDF: 805HTML: 315 -
WHAT ARE FUNGAL INFECTIONS?
4190PDF: 2384HTML: 27605de Pauw: 235 -
ROLE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
2024PDF: 800HTML: 1045 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1968PDF: 750HTML: 696 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
12346PDF: 1681HTML: 4179Cover letter: 198Figure 1: 204 -
A MULTICENTER ICET-A SURVEY ON ADHERENCE TO ANNUAL ORAL GLUCOSE TOLERANCE TEST (OGTT) SCREENING IN TRANSFUSION-DEPENDENT THALASSEMIA (TDT) PATIENTS - THE EXPERT CLINICIANS’ OPINION ON FACTORS INFLUENCING THE ADHERENCE AND ON ALTERNATIVE STRATEGIES FOR ADHERENCE OPTIMIZATION Survey on adherence to annual OGTT in thalassemia
2906PDF: 1332HTML: 159 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
2964PDF: 894HTML: 1951







